Cargando…

Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis

PURPOSE: Wild-type transthyretin-related amyloidosis cardiomyopathy (ATTRwt-CM) is an increasingly recognized cause of heart failure especially in elderly patients. The purpose of the present study was to determine retrospectively whether the quantitative indices of (99m)Tc-pyrophosphate (PYP) SPECT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogasawara, Kouji, Shiraishi, Shinya, Tsuda, Noriko, Sakamoto, Fumi, Oda, Seitarou, Takashio, Seiji, Tsujita, Kenichi, Hirai, Toshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068718/ https://www.ncbi.nlm.nih.gov/pubmed/34973114 http://dx.doi.org/10.1007/s11604-021-01221-6

Ejemplares similares

Comparison of 1-h with 3-h planar (99m)Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard
por: Saitou, Toshinori, et al.
Publicado: (2022)

Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
por: Watanabe, Satoru, et al.
Publicado: (2021)

Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT
por: Ren, Chao, et al.
Publicado: (2021)

Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Cardiac transthyretin amyloidosis (99m)Tc-DPD SPECT correlates with strain echocardiography and biomarkers
por: Löfbacka, Viktor, et al.
Publicado: (2020)

CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Extracardiac Accumulation of Technetium-99m-Pyrophosphate in Transthyretin Cardiac Amyloidosis
por: Takahashi, Koji, et al.
Publicado: (2021)

An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
por: Schatka, Imke, et al.
Publicado: (2021)

Radiopharmaceutical supply disruptions and the use of (99m)Tc-hydroxymethylene diphosphonate as an alternative to (99m)Tc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
por: Miller, Edward J., et al.
Publicado: (2022)

Pitfalls of the Semi-Quantitative Analyzing (99m)Tc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution
por: Zhu, Yuankai, et al.
Publicado: (2022)

Microcalcification and (99m)Tc-Pyrophosphate Uptake without Increased Bone Metabolism in Cardiac Tissue from Patients with Transthyretin Cardiac Amyloidosis
por: Mori, Atsushi, et al.
Publicado: (2023)

Technetium-99m pyrophosphate cardiac SPECT in endomyocardial biopsy negative cardiac amyloidosis
por: Krupa, Martin, et al.
Publicado: (2018)

Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours
por: Watanabe, Satoru, et al.
Publicado: (2023)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
por: Pilebro, Björn, et al.
Publicado: (2016)

Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
por: Hirakawa, Kyoko, et al.
Publicado: (2018)

Comparison of LDPI to SPECT perfusion imaging using (99m)Tc-sestamibi and (99m)Tc-pyrophosphate in a murine ischemic hind limb model of neovascularization
por: Hendrikx, Geert, et al.
Publicado: (2016)

Assessment of Interobserver Agreement in the Interpretation of (99m)Tc-PYP SPECT Imaging of Cardiac Amyloidosis
por: Imakhanova, Aiganym, et al.
Publicado: (2023)

Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
por: Hayashi, Hidetaka, et al.
Publicado: (2021)

(99m)Technetium‐pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study
por: Wlodarski, Richard, et al.
Publicado: (2022)

1-hour versus 3-hour (99m)Tc-PYP imaging to evaluate suspected cardiac transthyretin amyloidosis
por: Nichols, Kenneth J., et al.
Publicado: (2023)

Impact of (99m)Tc-GSA SPECT Image-Guided Inverse Planning on Dose–Function Histogram Parameters for Stereotactic Body Radiation Therapy Planning for Patients With Hepatocellular Carcinoma: A Dosimetric Comparison Study
por: Toya, Ryo, et al.
Publicado: (2019)

Scintigraphic Imaging of Inflammation in the Aortic Wall Using (99m)Tc-Pyrophosphate
por: Ilyushenkova, J.N., et al.
Publicado: (2021)

(99m)Tc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications
por: Lee, Joohee, et al.
Publicado: (2020)

Temporal Change in Longitudinal Strain After Domino Liver Transplantation With Liver Grafts Explanted From Patients With Hereditary Amyloidogenic Transthyretin Amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2020)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
por: Takashio, Seiji, et al.
Publicado: (2023)

Optimization of SPECT/CT imaging protocols for quantitative and qualitative (99m)Tc SPECT
por: Kupitz, Dennis, et al.
Publicado: (2021)

Clinical usefulness of (99m)Tc-HYNIC-TOC, (99m)Tc(V)-DMSA, and (99m)Tc-MIBI SPECT in the evaluation of pituitary adenomas
por: Vukomanovic, Vladimir R., et al.
Publicado: (2019)

Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
por: Manrique, Alain, et al.
Publicado: (2019)

Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients
por: Monfort, Astrid, et al.
Publicado: (2022)

(99m)Technetium‐pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy
por: Tahara, Nobuhiro, et al.
Publicado: (2021)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2023)

Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis
por: Okada, Masamitsu, et al.
Publicado: (2020)

Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report
por: Takashio, Seiji, et al.
Publicado: (2020)

Is 99mTc-diphosphonate uptake the earliest sign of cardiac amyloidosis development in asymptomatic Glu89Gln transthyretin gene mutation carriers?
por: Minutoli, Fabio, et al.
Publicado: (2015)

Comparison of Tc-99m pertechnetate images with dual-phase Tc 99m MIBI and SPECT images in primary hyperparathyroidism
por: Sager, Sait, et al.
Publicado: (2014)

Role of (99m)Tc-ECD SPECT in the Management of Children with Craniosynostosis
por: Barik, Mayadhar, et al.
Publicado: (2014)

Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
por: Liepe, Knut, et al.
Publicado: (2022)

Localization of In-111 Antimyosin Fab and (99m)Tc-Pyrophosphate in Reperfusion Myocardial Infarction Model
por: Lee, Dong Soo, et al.
Publicado: (1990)

Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
por: Shen, Christine P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g1r7r7666vivptedqo9rpht0jg